ATRX Loss in Soft Tissue Sarcomas Identifies Potential Vulnerability to TEAD Inhibitors
Researchers found that ATRX deficiency drives aggressive growth in soft-tissue sarcomas while sensitizing tumors to investigational TEAD inhibitors in preclinical ...



